August 1st, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Pharmaceutically active monoclonal antibody, human melanocortin-4 receptor (MC4R), treatment of weight loss, anorexia / cachexia, modulation of appetite and food intake, compositions including such mAbs or binding fragments thereof
July 31st, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
A clinically proven safe and effective innovative research formula to sustain healthy joints, promote joint flexibility and mobility and give comfort against stiffness and pain.
July 29th, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Need to in-license Ibuprofen Oral suspension for UK
July 28th, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Novel peptides for treating a large variety of cancers. The erbB receptor family is expressed in a variety of different human tumors including breast, head and neck, gastric, colorectal, prostate, bladder, renal, pancreatic, and ovarian. In some...
July 25th, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Fluid-based bio-optical sensor and portable reader
July 24th, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Methods and Compositions for Promoting Hair Growth: Treatment of Male and Female Androgenic Alopecia
July 23rd, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Rubicon has developed a generic equivalent, pleasant tasting, robust, stable orally disintegrating tablets of Loratadine which can be packed in unit dose blister packs and offers product launching opportunity in regulated and semi or non regulated market.
July 16th, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Both 200mg and 400mg strengths are available on CTD dossier with sufficient BE studies in clear colourless, pink and blue
July 14th, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
Our products (KH-207 and KD-30) related to treatment of osteoarthritis focus on increase of chondrogenesis through cartilage protection as well as beneficial effects (decrease of pain and stiffness and improvement of function). We propose an alterna
July 11th, 2010 Pharmalicensing.com Posted in Biotech Licensing No Comments »
To look for outlicensing opportunity around the world